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Recent advances in fast and inexpensive DNA sequencing have enabled the extensive study of genomic and
transcriptomic variation in humans. Human genomic variation is composed of sequence and structural
changes including single-nucleotide and multinucleotide variants, short insertions or deletions (indels), larger
copy number variants, and similarly sized copy neutral inversions and translocations. It is now well established
that any two genomes differ extensively and that structural changes constitute a prominent source of this
variation. There have also been major technological advances in RNA sequencing to globally quantify and
describe diversity in transcripts. Large consortia such as the 1000 Genomes Project and the ENCODE
(ENCyclopedia Of DNA Elements) Project are producing increasingly comprehensive maps outlining the
regions of the human genome containing variants and functional elements, respectively. Integration of genetic
variation data and extensive annotation of functional genomic elements, along with the ability to measure
global transcription, allow the impacts of genetic variants on gene expression to be resolved. There are
several well-established models by which genetic variants affect gene regulation depending on the type,
nature, and position of the variant with respect to the affected genes. These effects can be manifested in two
ways: changes to transcript sequences and isoforms by coding variants, and changes to transcript abundance
by dosage or regulatory variants. Here, we review the current state of how genetic variations impact gene
regulation locally and globally in the human genome.
© 2013 The Authors. Published by Elsevier Ltd.Open access under CC BY-NC-ND license.Introduction
Human genomes vary as a result of sequence and
structural changes. Sequence variation comprises
single-nucleotide andmultinucleotide variants (SNVs
and MNVs, respectively). Another class of variation
consists of small insertions or deletions (indels) of a
few nucleotides. Structural variation (SV) consists of
larger copy number variations (CNVs) including
deletions, duplications, and mobile-element inser-
tions; copy neutral inversions and translocations; and
chromosomal aneuploidies. Deciphering the func-
tional impacts of variants in the human genome
involves measuring their effects on gene expression.
Transcription directs the manufacturing of proteins
and functional RNAs, which in turn carry out the
physical work of a cell. Genetic variants are capable
of impacting transcriptional regulation in diverse
ways according to the variant's size, nature, anduthors. Published by Elsevier Ltd. Open access ulocation relative to the coding or regulatory regions of
the gene in question. In this review, we will discuss
the molecular effects of different types of genetic
variants on gene regulation, including the effects on
gene expression levels and transcript variability.Variation in the Human Genome
Genomic variation consists of relative differences
in the sequence, or in the arrangement of blocks of
sequence between different genomes. These differ-
ences constitute a natural phenomenon of human
genomes and are major contributors to human
phenotypic variation. Genetic variation can result in
benign or pathogenic phenotypes. Many genetic
variants underlie adaptive traits and have become
common in populations where they confer, or once
conferred, a selective advantage.J. Mol. Biol. (2013) 425, 3970–3977nder CC BY-NC-ND license.
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varying segments of DNA, measured in base pairs,
as well as by the nature and location of the events
relative to a reference genome. The type of variant
reflects whether DNA material was substituted,
gained (duplicated or inserted), lost, or rearranged
(inverted, translocated). Each variant is uniquely
described by the sequence and the position of the
variant relative to the reference sequence.
SNVs or point mutations are single-base-pair
changes in one sequence compared to another.
MNVs are changes in one sequence with respect to
another, which are a few base pairs in length. SNVs
and MNVs are substitution mutations where some
nucleotides in one genome are replaced with other
nucleotides in another, without any net gain or loss of
genetic material. SNVs and MNVs that occur in >1%
of individuals in a sampled population are usually
referred to as single-nucleotide polymorphisms
(SNPs) and multinucleotide polymorphisms
(MNPs), respectively. The 1000 Genomes Project's
latest effort mappedmore than 38million SNPs, 58%
of which were previously unknown, in 14 different
worldwide populations [1].
Indels are small insertions or deletions in one
genome with respect to another and are generally
between 1 and 50 bp in size. Indels that are not
multiples of 3 bp in length and that lie within coding
regions of genomic DNA result in frameshift muta-
tions; not surprisingly, within coding regions of the
genome, there is an enrichment of indels that are
multiples of 3 bp [2]. A recent study based on data
from the 1000 Genomes Project data has mapped
1.6 million indels in three populations using an
approach to optimize the sensitivity and specificity of
short indel discovery [3,4]. This study found that
21.8% of indel calls were novel to a database that
houses all known indels, dbSNP 135. Interestingly,
43–48% of called indels occupy only 4.03% of the
genome, clustering in homopolymer runs, tandem
repeats, or predicted hotspots. In the rest of the
genome, indels are rare, occurring 16 times less
often than SNPs. More than 75% of indels arise due
to polymerase slippage, while the remaining in-
stances result from simple deletions or forkhead
stalling and template switching [4].
Structural variants range in size from hundreds to
hundreds of thousands and even millions of base
pairs. These comprise both copy number variable
changes and copy neutral changes. CNVs consist of
deletions or insertions of stretches of DNA in one
genome compared to another. Deletions can be
either heterozygous or homozygous. However,
whole gene insertions have been found to be
present from 1 to upwards of 15 times in one
genome compared to another [5]. Insertions can be
tandem or dispersed in the genome. A predominant
class of insertions called mobile-element insertions
are those sequences that are derived from ancienttransposable elements and persist in the genome,
such as short and long interspersed nuclear ele-
ments (SINEs such as Alu elements and LINEs) [6].
To date, upwards of 28,000 unique CNVs have been
catalogued, several of which are thought to be
common in human populations [7]. There are on the
order of thousands of CNVs between genomes [3,8].
CNVs that are polymorphic in a population are
referred to as copy number polymorphisms.
Structural variation also includes similarly sized
copy number neutral events, in which there is no net
gain or loss of genomic content. These can be
sequence inversions, in which a stretch of DNA
sequence has been flipped between two endpoints,
or balanced chromosomal translocations, in which
two chromosomes have exchanged stretches of
DNA sequence in one genome versus another.
Successive, increasingly comprehensive efforts to
map all the variants in human genomes have
demonstrated that CNVs or SVs are responsible
for a much greater percentage of the total number of
base pairs differing between normal genomes than
SNPs [1,3,8–13]. Two normal genomes are estimat-
ed to differ by several percent of their length due to
CNVs or SVs, but only by 0.1% due to SNPs [9,14].
In fact, a significant proportion of variants lie in
regions where structural variation is inherently
common [3,7,8].
A clear picture of the genomic and population
distributions of genetic variants is beginning to
emerge due to massive variant mapping efforts in
worldwide populations and especially the 1000
Genomes Project. SVs and in particular CNVs are
distributed in a non-random fashion in the genome
and are biased towards ‘hotspots’ such as repetitive
sequences. CNVs are enriched in segmental dupli-
cations and are biased away from genes [7,12]. The
set of genes that is more likely impacted by CNVs is
enriched for genes involved in sensory perception
and interaction with the environment. Conversely,
CNVs are depleted in genes that occupy central
nodes in biological networks [8,15].
Variation in the human genome is extensive and is
now well understood. Many variants have been shown
to influence gene expression by several models,
outlined below. Several methods for measuring global
gene expression are employed in order to determine
the impact of genetic variants on gene regulation.Methods for Measuring Variation in
Genome-Wide Transcription
There are two major methods to quantify genome-
wide transcriptional activity in humans: gene expres-
sion microarrays and RNA sequencing (RNA-seq).
Early attempts to measure locus-specific transcrip-
tion involved quantitative PCR. However, the inven-
tion of DNA expression microarrays allowed for the
3972 Review: Impacts of human genetic variationfirst time an efficient protocol for measuring the
expression of multiple transcripts at once. These
arrays contain single-stranded DNA molecules that
tile known genes and splice variants. Total mRNA
samples from a test and control are converted to
cDNA, differentially labeled, and hybridized to the
array. Here, the relative differences in fluorescence
are measures of the relative amounts of certain
transcripts between the test and control sample.
RNA expression arrays were the standard for
measuring transcription for many years despite the
limitations that only known transcripts could be
quantified, quantification was always relative, and
cross-hybridization may sometimes render closely
related transcripts indistinguishable.
The advent of DNA sequencing technology has
allowed for even more precise methods for quanti-
fying transcription. The method of RNA-seq was
developed in order to directly sequence the total set
of RNA molecules from a sample in order to
measure variations in their abundance and se-
quence [16]. RNA-seq involves isolating all the
RNA from a cell, converting it to cDNA, sequencing
the cDNA fragments on high-throughput sequencing
machines, and mapping the reads back to the
genome. RNA-seq allows quantification of tran-
scripts by measuring read depth differences be-
tween a test and a control. The number of RNA-seq
reads that map to a particular locus can be used as a
measure of the relative abundance of that transcript
between samples. In single-end RNA-seq transcript
abundance is often measured by the number of
reads per kilobase per million mapped reads
(RPKM). However, paired-end RNA-seq generates
two reads per fragment. In this protocol it is only
appropriate to count those fragments in which both
reads are mappable. A common software suite for
analyzing RNA-seq data, Cufflinks, measures tran-
script abundance in fragments per kilobase of exon
per million mapped fragments (FPKM). In addition,
the base pair resolution of sequencing technologies
also allows for novel transcripts and transcript
sequence variants to be quantified. The use of
paired-end reads as opposed to single-end reads
allows more precise mapping and detection of splice
variants. Newly available strand-specific protocols
can now detect the strand of a DNA molecule from
which a particular transcript is derived [17]. In one
method, this is achieved by differentially labeling the
second strand in cDNA synthesis by using dUTP
instead of dTTP. RNA-seq protocols differ in the
methods used for capturing various types of
transcripts. For example, some protocols focus on
isolating only mRNA using poly-A selection. Other
protocols use RiboZero to deplete rRNA in order to
study all other RNA species, including lowly
expressed transcripts. RNA-seq in its various
forms has become the state of the art for quantifying
genome-wide transcriptional activity.Impact of Genetic Variation on
Transcript Sequence
The impact of single-nucleotide variations on tran-
script coding sequence is well established. Such
variation may result in synonymous or non-synony-
mous mutations. Synonymous mutations involve a
change in genomic sequence that does not alter the
encoded amino acid sequence. Non-synonymous
mutations include missense and nonsense mutations,
corresponding to a change in the encoded amino acid
sequence or the introduction of a premature stop
codon, respectively. Introduction of premature stop
codons in transcripts will likely either produce short-
ened peptides or initiate nonsense-mediated decay,
resulting in no functional protein being produced.
Additionally, SNVs that alter the initial methionine
codon of a transcript may render the sequence
untranslatable. SNVs that convert stop codons into
amino acid codonsmay alter the length of the encoded
peptide. MNVs may produce synonymous, or single or
multiple non-synonymous mutations [18].
Indels can affect coding sequence by producing
either non-frameshift or frameshift mutations. Non-
frameshift mutations occur when the length of the
indel is a multiple of 3, and only the part of the amino
acid sequence directly covered by the indel is
altered. Frameshift mutations occur when the length
of the indel is not a multiple of 3, and the entire amino
acid sequence to the 5′ end of the genomic variant
is affected.
Ten protein-coding genes have been identified
with a predicted indel rate greater than 2 × 10−5 per
generation across the coding sequence. Three of
these genes are known to be associated with
disease. HTT is associated with Huntington's dis-
ease. AR is associated with prostate cancer, spinal
and bulbar muscular dystrophy, and infertility.
ARID1B is associated with various forms of neuro-
developmental abormalities [4]. In general, it has
been found that indels are under stronger purifying
selection than SNPs in functional genomic regions
[4]. This is likely due to the strong deleterious effects
of frameshift mutations.
The impacts of indels on transcription have not
been ascertained to the same extent as that for
SNPs and SVs. However, it appears that despite
their low rates, the functional impacts of indels may
be considerable. In particular, the ~20 repeat
expansion diseases identified to date provide the
most well understood examples of indel effects on
transcription. All repeat expansion diseases that are
currently known to contain expansions within exons
contain the repeat sequence CAG⋅CTG. There are at
least 10 such diseases known including Huntington's
disease. The expansion results in an increase in
length of a polyglutamine (poly Q) tract in the protein
encoded by the gene [19]. The poly Q tract is thought
3973Review: Impacts of human genetic variationto render the protein toxic and lead to various
malfunctions [20].
CNVs can affect the coding complement of a
transcript by deleting or inserting exonic sequences
that may result in frameshift or non-frameshift
mutations, or splice variants depending on the length
or position of the CNV relative to the exons. CNVs
that affect intronic sequences may lead to alternative
splicing from the original sequence. Rearrange-
ments involving the red and green opsin gene
cluster on chromosome X can lead to the generation
of mosaic genes that cause various forms of red–
green color distortion. Total deletion of one or the
other type of opsin results in red–green color
blindness [21].
Other structural variants such as inversions or
translocations may affect the coding complement of
a gene if the event lies in the appropriate position.
For example, inversions that flip exonic sequences
will change the sequence of amino acids encoded by
the transcript and may induce missense or nonsense
mutations, or alter patterns of gene splicing by
altering the splice donor and acceptor sites.
Sequence variations may also affect untranslated
transcripts such as miRNAs and other small RNAs,
thereby affecting their function. For example, SNVs,
MNVs, or indels may cause perturbations in RNA
secondary structure, which may, in turn, result in
altered binding of the RNA in question to other
transcripts or genomic regions [22].Impact of Genetic Variants on Transcript
Abundance
There are two main ways in which genetic
variants may affect the level of expression of a
gene. CNVs may alter gene dosage by altering the
number of copies of a gene that is present in the
genome. SNVs or SVs may alter gene regulatory
elements, thus perturbing the assembly of the
transcription machinery. In both cases, variation at
the genomic level may result in differences in the
amount of expression of a transcript.
There have been several reports in the literature of
gene dosage effects due to variations in gene copy
number [7,8,11]. This phenomenon was known even
before the discovery that CNVs are a major source of
human genetic variation. As early as 1993, the
number of active copies of the cytochrome P450
CYP2D6 gene and the amount of metabolism of the
CYP2D6 substrate were shown to be correlated [23].
However, there have been few definitive demonstra-
tions in the literature of the direct effects of copy
number variants on gene expression. One of the
most conclusive studies of a gene dosage effect
showed that the salivary amylase (AMY1) gene copy
number, salivary amylase protein level, and the
starch content of the diets of several differentpopulations around the world are positively correlat-
ed [5]. The AMY1 gene copy number can range from
2 to 15 copies in populations worldwide. AMY1
encodes the enzyme salivary amylase, which
metabolizes starch. This work implies that high
AMY1 copy number was selected for in populations
with high starch content and that this increased gene
dosage leads to more efficient starch metabolism.
CNVs can also affect the amount of gene
expression when they occur in the regulatory
sequence elements of a gene. The specific effect
is determined by the type of regulatory element
affected (activator or repressor) and the way in which
it is affected, that is, altering the complement of
regulatory elements (e.g., deletion or duplication of
an activator) or the structure (e.g., novel insertion
that nullifies a repressor). A pathological example of
a CNV functioning in this way was demonstrated for
susceptibility to Crohn's disease (CD). Here, a 20-kb
deletion polymorphism immediately upstream of the
immunity-related GTPase family M (IRGM) gene,
and in perfect linkage equilibrium with the most
strongly associated CD SNP, causes the gene to
segregate in the population with two distinct up-
stream sequences. The deletion allele and reference
allele showed distinct IRGM expression patterns
[24]. These expression patterns modulate a biolog-
ical process implicated in CD. The CD association at
this locus results from a CNV in the upstream
regulatory region of the IRGM gene that likely affects
the expression of the gene in such a way as to cause
the phenotype.
Aside from examples of single loci, there has been
little work demonstrating the genome-wide effects of
CNV on transcription and in particular gene copy
number with gene expression activity. Recently, an
accumulation of CNV association studies has
produced several strong associations with various
phenotypes, indicating that CNVs have profound
effects on human health and disease, especially
neurological and developmental diseases [24–35].
CNVs have also been shown to be associated with
non-pathogenic traits such as height and body mass
index [36,37]. However, direct measurement of
these CNVs on transcription has been lacking. In
2007, the relationship between gene copy number
and gene expression was demonstrated [38]. Array
Comparative Genome Hybridization was used for
measuring DNA copy number, and expression
microarrays were used for measuring transcript
expression. A general positive correlation between
gene copy number and gene expression was found.
However, this study only interrogated 15,000 tran-
scripts and found that only 17% of the variation in
expression was explained by CNVs, while 80% was
explained by SNPs. Subsequent to this, there have
been a handful of studies investigating the genome-
wide effects of CNVs on expression. In 2010, a
similar trend was found using sequencing-based
3974 Review: Impacts of human genetic variationtechnologies for mapping structural variations and
measuring transcription genome-wide [39]. The next
year, Schlattl et al. examined the relationships
between different categories of copy number vari-
ants based on size, type, and overlap with genes,
and gene expression [40]. Using fine-scale CNV
mapping and expression data from 129 individuals
from the 1000 Genomes Project, they observed the
expression of 110 genes to be associated with
CNVs. This set of CNVs is enriched for large (N4 kb)
events. Again, a general positive correlation between
copy number and expression was demonstrated, and
this correlation was stronger with CNVs than with
nearby SNPs. The authors argue that these data
indicate a more causative role for CNVs than SNPs in
expression quantitative trait loci. Additionally, patho-
genic CNVs are more likely to contain aberrant
transcription of genes within or nearby the CNV [41].
Interestingly, although a general trend of positive
correlation between gene copy number and gene
expression has been observed, there are a minority of
cases reported for which the trend is reversed or for
which no change in expression is associated with
changes in copy number [40,42].
CNVs are also known to have a global effect on
the transcriptome [43]. In addition to these gross
genome-wide correlations between gene copy
number and gene transcription level, several unex-
pected local effects of CNVs on expression have
been observed. It has been well established that
most normal genomes contain several very large
CNVs [44]. Further, it is now apparent that some of
these large CNVs are indeed associated with
pathogenic phenotypes [41,45]. In particular, large
CNVs have been shown to exert a field effect on the
expression of genes within and around the CNV in
mice [46] and in human cell lines [41,47]. Such
effects are likely due to alterations of regulatory
elements for genes that lie outside of the immediate
copy variable region.
Copy neutral structural changes can affect tran-
scription either by directly creating breakpoints
within transcripts or by rearranging regulatory
elements and creating position effects. Such cis
regulatory position effects have been reported up to
1.5 Mb away from the gene in question [42,48].
Additionally, large structural variations may alter the
spatial distribution of chromosomes in the nucleus.
Such nuclear reorganization may disrupt cis and
trans regulatory interactions, producing adverse
effects on transcription [42].
Noncoding indels are capable of affecting gene
regulation by modulating transcription, silencing
genes, sequestering proteins involved in splicing and
cell architecture, and generating chromosomal fragility.
Tandem repeats may act as origins of replication,
intrinsic promoter components, transcription en-
hancers, blocks to transcription elongation, or gene
silencers. These effects are reviewed elsewhere [19].Gene regulatory elements are also affected by
point mutations, which in turn disrupt the assembly of
transcription machinery and the propagation of
transcriptional activating signals. Using a combina-
tion of chromatin immunoprecipitation followed by
sequencing (ChIP-seq) and deep RNA-seq,
Kasowski et al. showed that transcription factor
binding differences are associated with SNPs in
gene regulatory regions, and these differences were
correlated with mRNA abundance in 10 individual
cell lines [39]. This phenomenon was demonstrated
for two different transcription factors, PolII and NFκB.
Recently, Reddy et al. measured genome-wide
allelic differences in gene expression and transcrip-
tion factor binding in the individual NA12878 of 24
sequence-specific transcription factors. This study
leveraged an updated human reference genome that
included homozygous and heterozygous sites based
on 1000 Genomes Project data. A strong association
was found between allelic occupancy and expres-
sion within 100 bp of the transcription start site.
Additionally, sites showing differential allelic occu-
pancy were significantly enriched for disease-
associated and particularly autoimmune-associated
variants [49]. These results suggest that disease-
associated allelic variants in gene regulatory regions
have functional implications due to differences
in allelic transcription factor occupancy. The
ENCODE (ENCyclopedia Of DNA Elements) Project
aims to identify all functional elements in the human
genome, including coding and noncoding tran-
scripts, marks of accessible chromatin, and protein
binding sites [50–53]. To date, ChIP-seq has been
performed for 119 different transcription factors in
147 different cell lines. Expression has also been
quantified in many of these cell lines. The ENCODE
project represents the largest body of data for
studying the interaction between genomic variation
in gene regulatory regions with expression. Work to
understand the relationship between genomic vari-
ation in transcription factor binding sites and gene
expression is ongoing.Conclusions
Massive advances in our ability to map the entire
spectrum of genetic variants genome-wide at high
resolution have led to a better understanding of the
scope and distribution of human genomic variation.
In particular, the distribution of genetic variants with
respect to the functional regions of the genome
including genes and gene regulatory elements is
now well characterized. In addition, there have been
concurrent advances in our ability to quantify the
amount of gene expression as well as transcript
variability using allele-specific RNA-seq. Combining
genome-wide variant mapping and gene expression
analysis has led to the characterization of the
3975Review: Impacts of human genetic variationfunctional implications of the different types of
genetic variants on gene expression. SNVs, indels,
and SVs are all capable of affecting transcript
sequence. CNVs are able to directly affect gene
dosage, and SNVs, indels, and SVs that lie in gene
regulatory regions have been shown to perturb gene
expression in the corresponding genes. However,
genetic differences do not successfully explain all
the variability of gene expression. Indeed, epigenetic
changes such as DNA methylation and chromatin
modification also affect gene expression, and the
integration of other types of omics data (the
epigenome, chromatin folding, regulatory DNA ele-
ments, proteome, and metabolome among others)
will be useful in obtaining a more comprehensive
view by which genetic variation and other modifica-
tions affect gene expression. Such efforts are
already underway for a handful of genomes [54–56].
It is important to note that the work discussed here
pertains mostly to steady-state effects of variation on
expression. This is due to limitations in methodology.
Most methods can only detect steady-state gene
expression or transcription factor binding. However,
advances in single-cell technologies and analysis of
nascent transcripts are beginning to enable the study
of dynamic spatial and temporal expression [57–59].
Furthermore, we note that most of the global studies
to date that have examined the relationships between
the genome and the transcriptome have done so only
in lymphoblastoid cell lines. It remains to be seen if
these relationships persist in other cell types.
Many open questions remain regarding the rela-
tionship between genetic variant and gene regula-
tion. The full range of transcription factor binding
properties in relation to variations in regulatory
elements has not been described. In addition, the
regions of the genome that do not tolerate CNVs are
not fully catalogued, and the relationships among the
regions where CNVs exist and their genomic
sequence and chromatin structure are yet to be
resolved. Thus, the full extent of CNV on transcrip-
tion is not known. However, it is clear that we now
possess the technologies to comprehensively probe
the impact of genetic variations on gene regulation.
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SNV, single-nucleotide variant; MNV, multinucleotide
variant; SV, structural variation; CNV, copy number
variation; SNP, single-nucleotide polymorphism;
RNA-seq, RNA sequencing; CD, Crohn's disease.References
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